AXSOME THERAPEUTICS, INC. Current Portion of Long-Term Debt
AXSOME THERAPEUTICS, INC. (AXSM) had Current Portion of Long-Term Debt of $70.00 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:LongTermDebtCurrent · last filed 2026-08-10
- 2026-06-30: Long-term Debt, Current Maturities $70.00M.
- 2026-03-31: Long-term Debt, Current Maturities $70.00M.
- 2025-12-31: Long-term Debt, Current Maturities $70.00M.
- 2025-09-30: Long-term Debt, Current Maturities $70.00M.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2026-06-30 | $70.00M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $70.00M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $70.00M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $70.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $70.00M 10-Q · filed 2025-08-04 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-23 |
| 2020-06-30 | $6.55M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $4.57M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.60M 10-K · filed 2021-03-01 |
| 2019-09-30 | $648.52K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.16M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $535.77K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $3.29M 10-K · filed 2020-03-12 |
| 2018-09-30 | $3.29M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $3.28M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $3.28M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $3.27M 10-K · filed 2019-03-15 |
| 2017-09-30 | $2.72M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.90M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.08M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $269.16K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |